Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: CEREP

Market Cap 77.17M 89.46M 70.95M 66.78M 125M 8.44B 127M 841M 327M 4.14B 336M 329M 14.33B P/E 2024 *
-
P/E 2025 -
Enterprise Value 56.14M 65.07M 51.61M 48.58M 91.29M 6.14B 92.05M 612M 238M 3.01B 244M 239M 10.43B EV / Sales 2024
2.02x
EV / Sales 2025 1.67x
Free-Float
4.22%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 11/04/2024
Director TitleAgeSince
Chairman - 11/08/2023
Director/Board Member - 23/05/2024
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-0.42%+0.20%-11.90%-10.20% 43.44B
+0.76%+9.42%+303.09%+540.82% 33.54B
-4.74%-6.31%+10.75%-20.99% 28.48B
-0.47%-0.35%+3.38%+31.20% 29.2B
+0.06%+4.36%+13.31%+21.11% 25.34B
-0.02%+10.18% - - 14.36B
-0.98%-1.86%+53.43%+106.06% 13.05B
-0.83%-3.57%+2.55%+3.40% 12.67B
+1.67%+1.35%+105.56%+81.16% 12.28B
Average -0.55%+1.33%+60.02%+94.07% 23.6B
Weighted average by Cap. -0.67%+1.35%+62.71%+105.90%

Financials

2024 2025
Net sales 40.49M 46.93M 37.22M 35.04M 65.84M 4.43B 66.39M 441M 172M 2.17B 176M 172M 7.52B 41.1M 47.64M 37.79M 35.56M 66.83M 4.5B 67.39M 448M 174M 2.21B 179M 175M 7.63B
Net income 7.15M 8.29M 6.58M 6.19M 11.63M 783M 11.73M 77.95M 30.35M 384M 31.13M 30.46M 1.33B 4.78M 5.54M 4.4M 4.14M 7.78M 523M 7.84M 52.11M 20.29M 257M 20.81M 20.36M 888M
Net Debt -17.25M -20M -15.86M -14.93M -28.05M -1.89B -28.29M -188M -73.18M -926M -75.06M -73.46M -3.2B -21.03M -24.38M -19.34M -18.2M -34.2M -2.3B -34.49M -229M -89.23M -1.13B -91.51M -89.56M -3.91B
Logo CEREP
Eurofins Cerep specializes in the pre-clinical research of drugs for the pharmaceutical industry. Export accounts for 88.2% of net sales.
Employees
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!